XCMR has been awarded a $49,974 Phase 1 AFWERX award by the Department of Defense (DoD) to investigate DOD’s interest in next-generation personal protective equipment (PPE) for real-time inactivation of airborne biological threats. This funding supports XCMR’s efforts to create advanced PPE that offers continuous, real-time protection against airborne pathogens, aiming to revolutionize the way we safeguard healthcare workers, military personnel, and the general public from biological threats.
The Phase 1 award recognizes XCMR’s pioneering research in developing PPE equipped with Far UV-C technology. This cutting-edge equipment aims to provide continuous real-time disinfection of airborne biological threats, ensuring enhanced protection for those in high-risk environments.
AFWERX is an innovation program within the U.S. Department of Defense (DoD) that fosters the development of innovative technologies by collaborating with startups, small businesses, academic institutions, and industry partners. It was established to address critical challenges within the Air Force and other branches of the military by accelerating the development and deployment of breakthrough technologies. AFWERX connects innovators with DoD needs, creating pathways for small businesses and innovators to receive funding through programs like Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) initiatives.
This Phase 1 award will enable XCMR to conduct proof-of-concept research for its next-generation PPE, laying the groundwork for further development and potentially larger-scale projects. The success of this initiative could lead to additional funding, helping XCMR bring this life-saving technology to market.
XCMR’s receipt of the AFWERX Phase 1 award demonstrates the company’s leadership in developing next-generation PPE solutions. By combining innovative technologies with a focus on real-time pathogen inactivation, XCMR is working to enhance safety for healthcare workers, military personnel, and the public in the face of airborne biological threats.
